L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease

Clinical Nutrition

Volumn 24, Issue 6, 2005, Pages 988-997

  Yin, Wei Hsian ^a,b   Chen, Jaw Wen ^b,c   Tsai, Chingmin ^d   Chiang, Meng Cheng ^a   Young, Mason Shing ^a   Lin, Shing Jong ^b,c  

^a CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

Coronary artery disease; Endothelial function; L arginine; LDL oxidation

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; ARGININE; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; DIURETIC AGENT; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PADGEM PROTEIN; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CIRCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DEFECATION DISORDER; DIARRHEA; DRUG DOSE REGIMEN; DRUG FATALITY; DRUG MECHANISM; EPIGASTRIC PAIN; FEMALE; FUNCTION TEST; HEART PALPITATION; HUMAN; HYPERGLYCEMIA; LIPID BLOOD LEVEL; LIPID OXIDATION; MALE; MUSCLE DISEASE; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; SPRAIN; STATISTICAL SIGNIFICANCE; SUPPLEMENTATION; THORAX PAIN; VASCULAR ENDOTHELIUM; VOMITING;

ADMINISTRATION, ORAL; ARGININE; ASCORBIC ACID; COHORT STUDIES; CORONARY ARTERIOSCLEROSIS; CROSS-OVER STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; SAFETY;

EID: 28944452822     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2005.07.003     Document Type: Article

References (34)

1. S. Verma T.J. Anderson Fundamentals of endothelial function for the clinical cardiologist Circulation 105 2002 546-549
2. D. Behrendt P. Ganz Endothelial function: From vascular biology to clinical applications Am J Cardiol 90 Suppl. 2002 40L-48L
3. P. Libby Inflammation in atherosclerosis Nature 420 2002 868-874
4. P. Ganz J.A. Vita Testing endothelial vasomotor function: Nitric oxide, a multipotent molecule Circulation 108 2003 2049-2053
5. S. Verma M.R. Buchanan T.J. Anderson Endothelial function testing as a biomarker of vascular disease Circulation 108 2003 2054-2059
6. V. Schachinger M.B. Britten A.M. Zeiher Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 101 2000 1899-1906
7. M. Barton C.C. Haudenschild Endothelium and atherogenesis: Endothelial therapy revisited J Cardiovasc Pharmacol 38 Suppl. 2 2001 S23-S25
8. R.H. Boger S.M. Bode-Boger The clinical pharmacology of L-arginine Annu Rev Pharmacol Toxicol 41 2001 79-99
9. A.J. Maxwell J. Niebauer P.S. Lin P.S. Tsao D. Bomstein J.P. Cooke Hypercholesterolemia impairs exercise capacity: Role of nitric oxide J Am Coll Cardiol 29 1997 2A
10. M.A. Creager S.J. Gallagher X.J. Girerd S.M. Coleman V.J. Dzau J.P. Cooke l -arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans J Clin Invest 90 1992 1248-1253
11. H. Drexler A.M. Zeiher K. Meinzer H. Just Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patient by L-arginine Lancet 338 1991 1546-1550
12. J.L. Dubois-Rande R. Zelinsky F. Roudot et al. Effects of infusion of l -arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries Am J Cardiol 70 1992 1269-1275
13. A.A. Quyyumi N. Dakak J.G. Diodati D.M. Gilligan J.A. Panza R.O. Cannon III Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilatation J Am Coll Cardiol 30 1997 1220-1227
14. M.R. Adams R. McCredie W. Jessup J. Robinson D. Sullivan D.S. Celermajer Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease Atherosclerosis 129 1997 261-269
15. R. De Caterina P. Libby H.B. Peng et al. Nitric oxide decreases cytokine-induced endothelial activation. NO selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines J Clin Invest 96 1995 60-68
16. M.R. Adams W. Jessup D. Hailstones D.S. Celermajer l -arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules Circulation 95 1997 662-668
17. A. Blum R. Porat U. Rosenschein et al. Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris Am J Cardiol 83 1999 1488-1490
18. J. George S.B. Shmuel A. Roth et al. L-Arginine attenuates lymphocyte activation and anti-oxidized LDL antibody levels in patients undergoing angioplasty Atherosclerosis 174 2004 323-327
19. M.C. Corretti T.J. Anderson E.J. Benjamin et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the international brachial artery reactivity task force J Am Coll Cardiol 39 2002 257-265
20. N. Gokce J.F. Keaney Jr B. Frei et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease Circulation 99 1999 3234-3240
21. K.A. Pritchard Jr L. Groszek D.M. Smalley et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion Circ Res 77 1995 510-518
22. M.A. El-Missiry A.I. Othman M.A. Amer L-Arginine ameliorates oxidative stress in alloxan-induced experimental diabetes mellitus J Appl Toxicol 24 2004 93-97
23. G.N. Levine B. Frei S.N. Koulouris M.D. Gerhard J.F. Keaney Jr J.A. Vita Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease Circulation 93 1996 1107-1113
24. B. Frei L. England B.N. Ames Ascorbate is an outstanding antioxidant in human blood plasma Proc Natl Acad Sci USA 86 1989 6377-6381
25. T.S. Jackson A. Xu J.A. Vita J.F. Keaney Jr Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations Circ Res 83 1998 916-922
26. A. Meister Glutathione-ascorbic acid antioxidant system in animals J Biol Chem 269 1994 9397-9400
27. M.E. Murphy H.M. Piper H. Watanabe H. Sies Nitric oxide production by cultured aortic endothelial cells in response to thiol depletion and replenishment J Biol Chem 266 1991 19378-19383
28. J.A. Vita B. Frei M. Holbrook N. Gokce C. Leaf J.F. Keaney Jr L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial function in patients with coronary artery disease J Clin Invest 101 1998 1408-1414
29. P. Washko D. Rotrosen M. Levine Ascorbic acid transport and accumulation in human neutrophils J Biol Chem 264 1989 18996-19002
30. A. Huang J.A. Vita R.C. Venema J.F. Keaney Jr Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin J Biol Chem 275 2000 17399-17406
31. A. Tenenbaum E.Z. Fisman M. Motro L-arginine: Rediscovery in progress Cardiology 90 1998 153-159
32. J. Nanobashvili C. Neumayer A. Fuegl et al. Combined L-arginine and antioxidative vitamin treatment mollifies ischemia-reperfusion injury of skeletal muscle J Vasc Surg 39 2004 868-877
33. T.J. Anderson A. Uehata M.D. Gerhard et al. Close relation of endothelial function in the human coronary and peripheral circulation J Am Coll Cardiol 26 1995 1235-1241
34. L. Ceremuzynski T. Chamiec K. Herbaczynska-Cedro Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris Am J Cardiol 80 1997 331-333